Pacifichealth Laboratories Stock Profit Margin
PacificHealth Laboratories fundamentals help investors to digest information that contributes to PacificHealth Laboratories' financial success or failures. It also enables traders to predict the movement of PacificHealth Pink Sheet. The fundamental analysis module provides a way to measure PacificHealth Laboratories' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to PacificHealth Laboratories pink sheet.
PacificHealth |
PacificHealth Laboratories Company Profit Margin Analysis
PacificHealth Laboratories' Profit Margin measures overall efficiency of a company and shows its ability to withstand competition as well as defend against adverse conditions such as rising costs, falling prices, decline in sales or management distress. Profit margin tells investors how well the company executes on its overall pricing strategies as well as how effective the company in controlling its costs.
Current PacificHealth Laboratories Profit Margin | (0.14) % |
Most of PacificHealth Laboratories' fundamental indicators, such as Profit Margin, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, PacificHealth Laboratories is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
In a nutshell, Profit Margin indicator shows the amount of money the company makes from total sales or revenue. It can provide a good insight into companies in the same sector, as well as help to identify trends of a company from year to year.
CompetitionBased on the latest financial disclosure, PacificHealth Laboratories has a Profit Margin of -0.1415%. This is 104.67% lower than that of the Personal Products sector and 102.7% lower than that of the Consumer Staples industry. The profit margin for all United States stocks is 88.86% lower than that of the firm.
PacificHealth Profit Margin Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses PacificHealth Laboratories' direct or indirect competition against its Profit Margin to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of PacificHealth Laboratories could also be used in its relative valuation, which is a method of valuing PacificHealth Laboratories by comparing valuation metrics of similar companies.PacificHealth Laboratories is currently under evaluation in profit margin category among its peers.
PacificHealth Fundamentals
| Return On Equity | -0.75 | ||||
| Return On Asset | -0.25 | ||||
| Profit Margin | (0.14) % | ||||
| Operating Margin | (0.14) % | ||||
| Current Valuation | 571.89 K | ||||
| Shares Outstanding | 20.87 M | ||||
| Price To Earning | (0.34) X | ||||
| Price To Book | 0.71 X | ||||
| Price To Sales | 0.07 X | ||||
| Revenue | 6.91 M | ||||
| Gross Profit | 2.99 M | ||||
| EBITDA | (861.23 K) | ||||
| Net Income | (486.31 K) | ||||
| Cash And Equivalents | 324.48 K | ||||
| Cash Per Share | 0.02 X | ||||
| Total Debt | 54.86 K | ||||
| Debt To Equity | 0.07 % | ||||
| Current Ratio | 1.58 X | ||||
| Book Value Per Share | 0.04 X | ||||
| Cash Flow From Operations | (503.96 K) | ||||
| Earnings Per Share | (0.04) X | ||||
| Target Price | 2.8 | ||||
| Beta | -275.06 | ||||
| Market Capitalization | 87 | ||||
| Total Asset | 1.89 M | ||||
| Retained Earnings | (20.59 M) | ||||
| Working Capital | 676 K | ||||
| Current Asset | 1.84 M | ||||
| Current Liabilities | 1.17 M | ||||
| Z Score | -11.0 | ||||
| Net Asset | 1.89 M |
Currently Active Assets on Macroaxis
Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis. You can also try the CEOs Directory module to screen CEOs from public companies around the world.
Other Consideration for investing in PacificHealth Pink Sheet
If you are still planning to invest in PacificHealth Laboratories check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the PacificHealth Laboratories' history and understand the potential risks before investing.
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance |